 | • レポートコード：QYR9N2619 • 出版社/出版日：QYResearch / 2019年6月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、マイクロバイオーム治療薬の世界市場について調査・分析し、マイクロバイオーム治療薬のメーカー別販売量、市場シェア分析、種類別販売分析（タイプI、タイプII）、用途別販売分析（炎症性腸疾患（IBD）、希少疾病用医薬品、免疫腫瘍学、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。 ・マイクロバイオーム治療薬市場概要 ・マイクロバイオーム治療薬のメーカー別販売量・メーカー別シェア ・マイクロバイオーム治療薬の種類別販売量（タイプI、タイプII） ・マイクロバイオーム治療薬の用途別販売量（炎症性腸疾患（IBD）、希少疾病用医薬品、免疫腫瘍学、その他） ・マイクロバイオーム治療薬の地域別販売量・市場シェア ・マイクロバイオーム治療薬の米国市場規模（2014年-2019年） ・マイクロバイオーム治療薬のヨーロッパ市場規模（2014年-2019年） ・マイクロバイオーム治療薬の中国市場規模（2014年-2019年） ・マイクロバイオーム治療薬の日本市場規模（2014年-2019年） ・マイクロバイオーム治療薬の東南アジア市場規模（2014年-2019年） ・マイクロバイオーム治療薬のインド市場規模（2014年-2019年） ・マイクロバイオーム治療薬メーカー分析（企業概要、製品概要、販売量、売上、価格等） ・マイクロバイオーム治療薬のコスト分析 ・マイクロバイオーム治療薬販売チャネル、流通業者、顧客 ・マイクロバイオーム治療薬の世界市場動向・機会・成長要因・課題 ・マイクロバイオーム治療薬の種類別世界市場予測（タイプI、タイプII） ・マイクロバイオーム治療薬の用途別世界市場予測（炎症性腸疾患（IBD）、希少疾病用医薬品、免疫腫瘍学、その他） ・マイクロバイオーム治療薬の米国市場予測（2019年-2025年） ・マイクロバイオーム治療薬のヨーロッパ市場予測（2019年-2025年） ・マイクロバイオーム治療薬の中国市場予測（2019年-2025年） ・マイクロバイオーム治療薬の日本市場予測（2019年-2025年） ・マイクロバイオーム治療薬の東南アジア市場予測（2019年-2025年） ・マイクロバイオーム治療薬のインド市場予測（2019年-2025年） ... |
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that’s 2 to 6 pounds of bacteria in a 200-pound adult). These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The global Microbiome Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Microbiome Therapeutics market status and forecast, categorizes the global Microbiome Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Major manufacturers covered in this report
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Segment by Type
Type I
Type II
Segment by Application
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Table of Contents
Global Microbiome Therapeutics Sales Market Report 2019
1 Microbiome Therapeutics Market Overview
1.1 Microbiome TherapeuticsProduct Overview
1.2 Microbiome Therapeutics Segment by Type
1.2.1 Global Microbiome Therapeutics Sales Comparison by Types (2014-2025)
1.2.2 Type I
1.2.3 Type II
1.3 Microbiome Therapeutics Segment by Application
1.3.1 Global Microbiome Therapeutics Sales Comparison by Application (2014-2025)
1.3.1 Inflammatory Bowel Disease (IBD)
1.3.2 Orphan Drug
1.3.3 Immuno-oncology
1.3.4 Others
1.4 Microbiome Therapeutics Market by Region
1.4.1 Global Microbiome Therapeutics Revenue Comparison by Region (2014-2025)
1.4.2 United States Microbiome Therapeutics Status and Prospect (2014-2025)
1.4.3 Europe Microbiome Therapeutics Status and Prospect (2014-2025)
1.4.4 China Microbiome Therapeutics Status and Prospect (2014-2025)
1.4.5 Japan Microbiome Therapeutics Status and Prospect (2014-2025)
1.4.6 Southeast Asia Microbiome Therapeutics Status and Prospect (2014-2025)
1.4.7 India Microbiome Therapeutics Status and Prospect (2014-2025)
1.5 Global Microbiome Therapeutics Sales and Revenue (2014-2025)
1.5.1 Global Microbiome Therapeutics Sales and Growth Rate (2014-2025)
1.5.2 Global Microbiome Therapeutics Revenue and Growth Rate (2014-2025)
2 Microbiome Therapeutics by Company, Region, Type and Application
2.1 Global Microbiome Therapeutics Market Competition by Companies
2.1.1 Global Microbiome Therapeutics Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Microbiome Therapeutics Revenue Market Share by Company (2014-2019)
2.2 Global Microbiome Therapeutics Sales and Revenue by Region
2.2.1 Global Microbiome Therapeutics Sales Market Share by Region (2014-2019)
2.2.2 Global Microbiome Therapeutics Revenue Market Share by Region (2014-2019)
2.3 Global Microbiome Therapeutics Sales and Revenue by Type
2.3.1 Global Microbiome Therapeutics Sales Market Share by Type (2014-2019)
2.3.2 Global Microbiome Therapeutics Revenue Market Share by Type (2014-2019)
2.4 Global Microbiome Therapeutics Sales by Application
3 United States Microbiome Therapeutics Sales, Revenue and Price
3.1 United States Microbiome Therapeutics Sales and Revenue (2014-2019)
3.1.1 United States Microbiome Therapeutics Sales Growth Rate (2014-2019)
3.1.2 United States Microbiome Therapeutics Revenue Growth Rate (2014-2019)
3.1.3 United States Microbiome Therapeutics Price Trend (2014-2019)
3.2 United States Microbiome Therapeutics Sales Market Share by Company
3.3 United States Microbiome Therapeutics Sales Market Share by Type
3.4 United States Microbiome Therapeutics Sales Market Share by Application
4 Europe Microbiome Therapeutics Sales, Revenue and Price
4.1 Europe Microbiome Therapeutics Sales and Value (2014-2019)
4.1.1 Europe Microbiome Therapeutics Sales Growth Rate (2014-2019)
4.1.2 Europe Microbiome Therapeutics Revenue Growth Rate (2014-2019)
4.1.3 Europe Microbiome Therapeutics Price Trend (2014-2019)
4.2 Europe Microbiome Therapeutics Sales Market Share by Company
4.3 Europe Microbiome Therapeutics Sales Market Share by Type
4.4 Europe Microbiome Therapeutics Sales Market Share by Application
5 China Microbiome Therapeutics Sales, Revenue and Price
5.1 China Microbiome Therapeutics Sales and Revenue (2014-2019)
5.1.1 China Microbiome Therapeutics Sales Growth Rate (2014-2019)
5.1.2 China Microbiome Therapeutics Revenue Growth Rate (2014-2019)
5.1.3 China Microbiome Therapeutics Price Trend (2014-2019)
5.2 China Microbiome Therapeutics Sales Market Share by Company
5.3 China Microbiome Therapeutics Sales Market Share by Type
5.4 China Microbiome Therapeutics Sales Market Share by Application
6 Japan Microbiome Therapeutics Sales, Revenue and Price
6.1 Japan Microbiome Therapeutics Sales and Value (2014-2019)
6.1.1 Japan Microbiome Therapeutics Sales Growth Rate (2014-2019)
6.1.2 Japan Microbiome Therapeutics Revenue Growth Rate (2014-2019)
6.1.3 Japan Microbiome Therapeutics Price Trend (2014-2019)
6.2 Japan Microbiome Therapeutics Sales Market Share by Company
6.3 Japan Microbiome Therapeutics Sales Market Share by Type
6.4 Japan Microbiome Therapeutics Sales Market Share by Application
7 Southeast Asia Microbiome Therapeutics Sales, Revenue and Price
7.1 Southeast Asia Microbiome Therapeutics Sales and Value (2014-2019)
7.1.1 Southeast Asia Microbiome Therapeutics Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Microbiome Therapeutics Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Microbiome Therapeutics Price Trend (2014-2019)
7.2 Southeast Asia Microbiome Therapeutics Sales Market Share by Company
7.3 Southeast Asia Microbiome Therapeutics Sales Market Share by Type
7.4 Southeast Asia Microbiome Therapeutics Sales Market Share by Application
8 India Microbiome Therapeutics Sales, Revenue and Price
8.1 India Microbiome Therapeutics Sales and Value (2014-2019)
8.1.1 India Microbiome Therapeutics Sales Growth Rate (2014-2019)
8.1.2 India Microbiome Therapeutics Revenue Growth Rate (2014-2019)
8.1.3 India Microbiome Therapeutics Price Trend (2014-2019)
8.2 India Microbiome Therapeutics Sales Market Share by Company
8.3 India Microbiome Therapeutics Sales Market Share by Type
8.4 India Microbiome Therapeutics Sales Market Share by Application
9 Company Profiles and Key Figures in Microbiome Therapeutics Business
9.1 Seres Therapeutics
9.1.1 Seres Therapeutics Microbiome Therapeutics Production Sites and Area Served
9.1.2 Microbiome Therapeutics Specification and Application
9.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Assembly Biosciences
9.2.1 Assembly Biosciences Microbiome Therapeutics Production Sites and Area Served
9.2.2 Microbiome Therapeutics Specification and Application
9.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Synthetic Biologics
9.3.1 Synthetic Biologics Microbiome Therapeutics Production Sites and Area Served
9.3.2 Microbiome Therapeutics Specification and Application
9.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Interxon
9.4.1 Interxon Microbiome Therapeutics Production Sites and Area Served
9.4.2 Microbiome Therapeutics Specification and Application
9.4.3 Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 PureTech
9.5.1 PureTech Microbiome Therapeutics Production Sites and Area Served
9.5.2 Microbiome Therapeutics Specification and Application
9.5.3 PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Synlogic
9.6.1 Synlogic Microbiome Therapeutics Production Sites and Area Served
9.6.2 Microbiome Therapeutics Specification and Application
9.6.3 Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Enterome BioScience
9.7.1 Enterome BioScience Production Sites and Area Served
9.7.2 Microbiome Therapeutics Specification and Application
9.7.3 Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 4D Pharma
9.8.1 4D Pharma Microbiome Therapeutics Production Sites and Area Served
9.8.2 Microbiome Therapeutics Specification and Application
9.8.3 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Second Genome
9.9.1 Second Genome Microbiome Therapeutics Production Sites and Area Served
9.9.2 Microbiome Therapeutics Specification and Application
9.9.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served
9.10 AOBiome
9.10.1 AOBiome Microbiome Therapeutics Production Sites and Area Served
9.10.2 Microbiome Therapeutics Specification and Application
9.10.3 AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business and Markets Served
9.11 C3 Jian
9.12 Rebiotix
9.13 MicroBiome Therapeutics LLC
9.14 Metabiomics
9.15 Ritter Pharmaceuticals
9.16 Symberix
9.17 OpenBiome
9.18 Azitra
9.19 Symbiotix Biotherapies
9.20 Osel
9.21 Metabogen
10 Microbiome Therapeutics Maufacturing Cost Analysis
10.1 Microbiome Therapeutics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Microbiome Therapeutics
10.4 Microbiome Therapeutics Industrial Chain Analysis
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Microbiome Therapeutics Distributors List
11.3 Microbiome Therapeutics Customers
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors
13 Microbiome Therapeutics Market Forecast
13.1 Global Microbiome Therapeutics Sales, Revenue and Price Forecast
13.1.1 Global Microbiome Therapeutics Sales Growth Forecast (2019-2025)
13.1.2 Global Microbiome Therapeutics Revenue Growth Forecast (2019-2025)
13.1.3 Global Microbiome Therapeutics Price Trend Forecast (2019-2025)
13.2 Global Microbiome Therapeutics Forecast by Region
13.2.1 Global Microbiome Therapeutics Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Microbiome Therapeutics Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Microbiome Therapeutics Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Microbiome Therapeutics Forecast by Type
13.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2019-2025)
13.3.2 Global Microbiome Therapeutics Revenue Forecast by Type (2019-2025)
13.3.3 Global Microbiome Therapeutics Price Forecast by Type (2019-2025)
13.4 Global Microbiome Therapeutics Forecast by Application
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
Market Breakdown by Region: Microbiome Therapeutics Sales (K Units) and Value (Revenue: Million US$)
Market Breakdown by Type: Microbiome Therapeutics Sales (K Units) and Revenue (Million US$)
Market Breakdown by Application: Microbiome Therapeutics Sales (Jan)
Figure Microbiome Therapeutics Product Picture
Table Global Microbiome Therapeutics Sales (K Units) Growth Rate by Types (2014-2025)
Figure Global Microbiome Therapeutics Sales Market Share by Types in 2018
Figure Type I Product Picture
Figure Type II Product Picture
Table Global Microbiome Therapeutics Sales (K Units) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Microbiome Therapeutics by Application in 2018
Figure Inflammatory Bowel Disease (IBD) Examples
Figure Orphan Drug Examples
Figure Immuno-oncology Examples
Figure Others Examples
Table Global Market Microbiome Therapeutics Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Microbiome Therapeutics Sales (K Units) Growth Rate (2014-2025)
Figure Global Microbiome Therapeutics Revenue (Million USD) Growth Rate (2014-2025)
Table Global Microbiome Therapeutics Sales (K Units) of Key Companies (2014-2019)
Figure Global Microbiome Therapeutics Sales by Company in 2018
Table Global Microbiome Therapeutics Sales Share by Company (2014-2019)
Figure Global Microbiome Therapeutics Sales Share by Company in 2018
Table Global Microbiome Therapeutics Revenue (Million USD) by Company (2014-2019)
Figure Global Microbiome Therapeutics Revenue (Million USD) by Company in 2018
Table Global Microbiome Therapeutics Revenue Share by Company (2014-2019)
Figure Global Microbiome Therapeutics Revenue Share by Company in 2018
Table Global Microbiome Therapeutics Sales (K Units) Market Share by Region (2014-2019)
Table Global Microbiome Therapeutics Sales Share by Region (2014-2019)
Figure Global Microbiome Therapeutics Sales Share by Region in 2018
Table Global Microbiome Therapeutics Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Microbiome Therapeutics Revenue Share by Region (2014-2019)
Figure Global Microbiome Therapeutics Revenue Market Share by Region In 2018
Table Global Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table Global Microbiome Therapeutics Sales Share by Type (2014-2019)
Figure Global Microbiome Therapeutics Sales Growth Rate by Type in 2018
Table Global Microbiome Therapeutics Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Microbiome Therapeutics Revenue Share by Type (2014-2019)
Figure Global Microbiome Therapeutics Revenue Growth Rate by Type in 2018
Table Global Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Table Global Microbiome Therapeutics Sales Share by Application (2014-2019)
Figure Global Microbiome Therapeutics Sales Market Share by Application in 2018
Figure United States Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table United States Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table United States Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure United States Microbiome Therapeutics Sales Market Share by Company in 2018
Table United States Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table United States Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure United States Microbiome Therapeutics Sales Market Share by Type in 2018
Table United States Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table United States Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure United States Microbiome Therapeutics Sales Market Share by Application in 2018
Figure Europe Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure Europe Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table Europe Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table Europe Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure Europe Microbiome Therapeutics Sales Market Share by Company in 2018
Table Europe Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table Europe Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure Europe Microbiome Therapeutics Sales Market Share by Type in 2018
Table Europe Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table Europe Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure Europe Microbiome Therapeutics Sales Market Share by Application in 2018
Figure China Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure China Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table China Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table China Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure China Microbiome Therapeutics Sales Market Share by Company in 2018
Table China Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table China Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure China Microbiome Therapeutics Sales Market Share by Type in 2018
Table China Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table China Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure China Microbiome Therapeutics Sales Market Share by Application in 2018
Figure Japan Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure Japan Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table Japan Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table Japan Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure Japan Microbiome Therapeutics Sales Market Share by Company in 2018
Table Japan Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table Japan Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure Japan Microbiome Therapeutics Sales Market Share by Type in 2018
Table Japan Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table Japan Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure Japan Microbiome Therapeutics Sales Market Share by Application in 2018
Figure Southeast Asia Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table Southeast Asia Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table Southeast Asia Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Sales Market Share by Company in 2018
Table Southeast Asia Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table Southeast Asia Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Sales Market Share by Type in 2018
Table Southeast Asia Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table Southeast Asia Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure Southeast Asia Microbiome Therapeutics Sales Market Share by Application in 2018
Figure India Microbiome Therapeutics Sales (K Units) and Growth Rate (2014-2019)
Figure India Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Microbiome Therapeutics Price (USD/Unit) Trend (2014-2019)
Table India Microbiome Therapeutics Sales (K Units) by Company (2014-2019)
Table India Microbiome Therapeutics Sales Market Share by Company (2014-2019)
Figure India Microbiome Therapeutics Sales Market Share by Company in 2018
Table India Microbiome Therapeutics Sales (K Units) by Type (2014-2019)
Table India Microbiome Therapeutics Sales Market Share by Type (2014-2019)
Figure India Microbiome Therapeutics Sales Market Share by Type in 2018
Table India Microbiome Therapeutics Sales (K Units) by Application (2014-2019)
Table India Microbiome Therapeutics Sales Market Share by Application (2014-2019)
Figure India Microbiome Therapeutics Sales Market Share by Application in 2018
Table Seres Therapeutics Microbiome Therapeutics Production Sites and Area Served
Table Seres Therapeutics Microbiome Therapeutics Specification and Application
Table Seres Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Seres Therapeutics Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Seres Therapeutics Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Seres Therapeutics Microbiome Therapeutics Main Business and Markets Served
Table Assembly Biosciences Microbiome Therapeutics Production Sites and Area Served
Table Assembly Biosciences Microbiome Therapeutics Specification and Application
Table Assembly Biosciences Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Assembly Biosciences Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Assembly Biosciences Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Assembly Biosciences Microbiome Therapeutics Main Business and Markets Served
Table Synthetic Biologics Microbiome Therapeutics Production Sites and Area Served
Table Synthetic Biologics Microbiome Therapeutics Specification and Application
Table Synthetic Biologics Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Synthetic Biologics Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Synthetic Biologics Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Synthetic Biologics Microbiome Therapeutics Main Business and Markets Served
Table Interxon Microbiome Therapeutics Production Sites and Area Served
Table Interxon Microbiome Therapeutics Specification and Application
Table Interxon Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Interxon Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Interxon Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Interxon Microbiome Therapeutics Main Business and Markets Served
Table PureTech Microbiome Therapeutics Production Sites and Area Served
Table PureTech Microbiome Therapeutics Specification and Application
Table PureTech Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure PureTech Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure PureTech Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure PureTech Microbiome Therapeutics Main Business and Markets Served
Table Synlogic Microbiome Therapeutics Production Sites and Area Served
Table Synlogic Microbiome Therapeutics Specification and Application
Table Synlogic Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Synlogic Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Synlogic Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Synlogic Microbiome Therapeutics Main Business and Markets Served
Table Enterome BioScience Microbiome Therapeutics Production Sites and Area Served
Table Enterome BioScience Microbiome Therapeutics Specification and Application
Table Enterome BioScience Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Enterome BioScience Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Enterome BioScience Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Enterome BioScience Microbiome Therapeutics Main Business and Markets Served
Table 4D Pharma Microbiome Therapeutics Production Sites and Area Served
Table 4D Pharma Microbiome Therapeutics Specification and Application
Table 4D Pharma Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure 4D Pharma Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure 4D Pharma Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure 4D Pharma Microbiome Therapeutics Main Business and Markets Served
Table Second Genome Microbiome Therapeutics Production Sites and Area Served
Table Second Genome Microbiome Therapeutics Specification and Application
Table Second Genome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Second Genome Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure Second Genome Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure Second Genome Microbiome Therapeutics Main Business and Markets Served
Table AOBiome Microbiome Therapeutics Production Sites and Area Served
Table AOBiome Microbiome Therapeutics Specification and Application
Table AOBiome Microbiome Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure AOBiome Microbiome Therapeutics Sales Growth Rate (2014-2019)
Figure AOBiome Microbiome Therapeutics Revenue Share in International Market (2014-2019)
Figure AOBiome Microbiome Therapeutics Main Business and Markets Served
Table C3 Jian Production Sites and Area Served
Table Rebiotix Production Sites and Area Served
Table MicroBiome Therapeutics LLC Production Sites and Area Served
Table Metabiomics Production Sites and Area Served
Table Ritter Pharmaceuticals Production Sites and Area Served
Table Symberix Production Sites and Area Served
Table OpenBiome Production Sites and Area Served
Table Azitra Production Sites and Area Served
Table Symbiotix Biotherapies Production Sites and Area Served
Table Osel Production Sites and Area Served
Table Metabogen Production Sites and Area Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Microbiome Therapeutics Distributors List
Table Microbiome Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Microbiome Therapeutics Price (USD/Unit) and Trend Forecast (2019-2025)
Table Global Microbiome Therapeutics Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Microbiome Therapeutics Sales Market Share Forecast by Regions (2019-2025)
Figure Global Microbiome Therapeutics Sales Market Share Forecast by Regions in 2025
Table Global Microbiome Therapeutics Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Microbiome Therapeutics Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Microbiome Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure United States Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate Forecast (2019-2025)
Figure China Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Microbiome Therapeutics Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Microbiome Therapeutics Sales (K Units) Forecast by Type (2019-2025)
Figure Global Microbiome Therapeutics Sales Market Share Forecast by Type (2019-2025)
Table Global Microbiome Therapeutics Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Microbiome Therapeutics Revenue Market Share Forecast by Type (2019-2025)
Table Global Microbiome Therapeutics Price (USD/Unit) Forecast by Type (2019-2025)
Table Global Microbiome Therapeutics Sales (K Units) Forecast by Application (2019-2025)
Figure Global Microbiome Therapeutics Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のヒトマイクロバイオーム市場：市場規模・現状・予測 The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a to…- 世界の炎症性腸疾患（IBD）治療学市場：市場規模・現状・予測 Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive t…
- 世界のサンドホフ病治療薬市場2019 The global Sandhoff Disease Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Sandhoff Disease Therapeutics market status and forecast, categorizes the global Sandhoff Disease The…
- 世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測 Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attribu…
- 世界の獣医感染症治療薬市場：市場規模・現状・予測 In 2018, the global Veterinary Infectious Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Veterinary Infectious Disease Therapeutics status, future forecast, growth opportu…